Projects using AI for disease monitoring

The VASCUL-AID study, for which NDS is a consortium partner, will revolutionise the management of vascular diseases, specifically Abdominal Aortic Aneurysm (AAA) and Peripheral Arterial Disease (PAD). Our mission is to predict the risk of cardiovascular events and disease progression, ultimately improving the quality of life and care for patients.

For the first time, VASCUL-AID offers a ground-breaking solution to identify patients who are at high risk for AAA growth or PAD progression, enabling early intervention and personalised prevention strategies. Our cutting-edge AI-driven platform integrates a wide range of data, including imaging, proteomic and genomic data, as well as lifestyle information from wearable devices. This comprehensive approach allows us to deliver clinically relevant and cost-effective predictions, supporting both patients and clinicians in making better-informed decisions.